Docosatetraenoic (DTA) 22:4 n6

Optimal result: 0.45 – 1.25 wt %

Elevations of DTA/adrenic acid are seen in diets rich in omega-6s and arachidonic acid (animal meat/fats and eggs). The clinical significance of adrenic acid is still being studied. Its importance in fetal development, osteoarthritis, and vasodilation have been documented, though some of the research is in animal studies. It has also been found to be elevated in patients with nonalcoholic fatty liver (NAFLD) and nonalcoholic steatohepatitis (NASH). Because its precursor is AA, elevations due to high AA intake have deleterious associations as outlined above in the AA section.

Diets low in omega-6 fatty acids and arachidonic acid would result in lower levels of DTA/adrenic acid. The clinical significance of low levels may be relevant in infant and fetal development.

Docosatetraenoic acid (DTA) is a very long chain omega-6 fatty acid with 22 carbons and 4 double bonds (22:4n6).

It is synthesized by adding 2 carbons atoms to the backbone of arachidonic acid using the elongase enzyme. It is sometimes referred to by its common name adrenic acid and is one of the most abundant fatty acids in the early human brain and the adrenal gland. DTA has not been well studied, though it has recently been shown to have important physiologic functions. It is now believed to be a pro-resolving mediator in inflammation by blocking neutrophilic metabolites and dampening the inflammation response. For example, in osteoarthritis DTA enhances phagocytosis by macrophages which clears products of cartilage breakdown in the joint space. Supplementation of DTA is being studied as a promising intervention in osteoarthritis to dampen inflammation and prevent structural damage.

Docosatetraenoic acid (DTA) is a very long chain omega-6 fatty acid with 22 carbons and 4 double bonds (22:4n6).

It is synthesized by adding 2 carbons atoms to the backbone of arachidonic acid using the elongase enzyme. It is sometimes referred to by its common name adrenic acid and is one of the most abundant fatty acids in the early human brain and the adrenal gland. DTA has not been well studied, though it has recently been shown to have important physiologic functions. It is now believed to be a pro-resolving mediator in inflammation by blocking neutrophilic metabolites and dampening the inflammation response. For example, in osteoarthritis DTA enhances phagocytosis by macrophages which clears products of cartilage breakdown in the joint space. Supplementation of DTA is being studied as a promising intervention in osteoarthritis to dampen inflammation and prevent structural damage.

Much like AA (its precursor) DTA/adrenic acid is an important component of infant development. DTA is the third most abundant PUFA in the brain and it is necessary for neural tissue development. DTA is also prevalent in the vasculature. It is metabolized to biologically active prostaglandins and epoxyeicosatrienoic acids (EETs) which activate smooth muscle channels causing relaxation and vasodilation. There is some literature to also support DTA/adrenic acid’s role in inducing oxidative stress and cell death through modulating superoxide dismutase enzymes.

References:

- Kopf PG, Zhang DX, Gauthier KM, et al. Adrenic acid metabolites as endogenous endothelium-derived and zona glomerulosa-derived hyperpolarizing factors. Hypertension. 2010;55(2):547-554.

- Brouwers H, Jonasdottir H, Kwekkeboom J, et al. Adrenic acid as a novel anti-inflammatory player in osteoarthritis. Osteoarthritis and Cartilage. 2018;26:S126.

- Hadley KB, Ryan AS, Forsyth S, Gautier S, Salem N. The essentiality of arachidonic acid in infant development. Nutrients. 2016;8(4):216.

- Yi XY, Gauthier KM, Cui L, Nithipatikom K, Falck JR, Campbell WB. Metabolism of adrenic acid to vasodilatory 1alpha,1beta-dihomo-epoxyeicosatrienoic acids by bovine coronary arteries. American journal of physiology Heart and circulatory physiology. 2007;292(5):H2265-2274.

- Nababan SHH, Nishiumi S, Kawano Y, Kobayashi T, Yoshida M, Azuma T. Adrenic acid as an inflammation enhancer in non-alcoholic fatty liver disease. Archives of biochemistry and biophysics. 2017;623:64-75.

Docosatetraenoic (DTA) 22:4 n6
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond Docosatetraenoic (DTA) 22:4 n6 — 10,000+ markers explained
One Docosatetraenoic (DTA) 22:4 n6 result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro